The HIV-1 reverse transcriptase connection domain from treatment-experienced patients contributes to AZT resistance

被引：0
|
作者：
Nikolenko, G. N.
Frankenberry, K. A.
Palmer, S.
Maldarelli, F.
Mellors, J. W.
Coffin, J. M.
Pathak, V. K.
机构：
[1] NCI, HIV Drug Resistance Program, Frederick, MD 21701 USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
来源：
ANTIVIRAL THERAPY | 2006年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S142 / S142
页数：1
相关论文
共 50 条
  • [1] Mutations in the thumb-connection and RNase H domain of HIV type-1 reverse transcriptase of antiretroviral treatment-experienced patients
    Waters, Joshua M.
    O'Neal, Wesley
    White, Kirsten L.
    Wakeford, Charles
    Lansdon, Eric B.
    Harris, Jeanette
    Svarovskaia, Evguenia S.
    Miller, Michael D.
    Borroto-Esoda, Katyna
    ANTIVIRAL THERAPY, 2009, 14 (02) : 231 - 239
  • [2] The Use of Nucleoside Reverse Transcriptase Inhibitors Sparing Regimens in Treatment-Experienced HIV-1 Infected Patients
    Di Biagio, Antonio
    Ricci, Elena
    Viscoli, Claudio
    Mesini, Alessio
    Menzaghi, Barbara
    Carenzi, Laura
    Orofino, Giancarlo
    Parruti, Giustino
    Martinelli, Canio
    Madeddu, Giordano
    De Socio, Giuseppe V.
    Franzetti, Marco
    Quirino, Tiziana
    Bonfanti, Paolo
    CURRENT HIV RESEARCH, 2013, 11 (03) : 179 - 186
  • [3] Zidovudine (AZT) Monotherapy Selects for the A360V Mutation in the Connection Domain of HIV-1 Reverse Transcriptase
    Brehm, Jessica H.
    Scott, Yanille
    Koontz, Dianna L.
    Perry, Steven
    Hammer, Scott
    Katzenstein, David
    Mellors, John W.
    Sluis-Cremer, Nicolas
    PLOS ONE, 2012, 7 (02):
  • [4] HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naive HIV-infected individuals
    Bokharaei-Salim, Farah
    Esghaei, Maryam
    Khanaliha, Khadijeh
    Kalantari, Saeed
    Marjani, Arezoo
    Fakhim, Atousa
    Keyvani, Hossein
    PLOS ONE, 2020, 15 (03):
  • [5] Should we include connection domain mutations of HIV-1 reverse transcriptase in HIV resistance testing?
    Gotte, Matthias
    PLOS MEDICINE, 2007, 4 (12) : 1858 - 1861
  • [6] RESISTANCE TO DDI AND SENSITIVITY TO AZT INDUCED BY A MUTATION IN HIV-1 REVERSE-TRANSCRIPTASE
    STCLAIR, MH
    MARTIN, JL
    TUDORWILLIAMS, G
    BACH, MC
    VAVRO, CL
    KING, DM
    KELLAM, P
    KEMP, SD
    LARDER, BA
    SCIENCE, 1991, 253 (5027) : 1557 - 1559
  • [7] Darunavir: In treatment-experienced pediatric patients with HIV-1 infection
    McKeage K.
    Scott L.J.
    Pediatric Drugs, 2010, 12 (2) : 123 - 131
  • [8] Antiretroviral regimens for treatment-experienced patients with HIV-1 infection
    Lagnese, Meena
    Daar, Eric S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (05) : 687 - 700
  • [9] Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in experienced patients
    Marcelin, A
    Roquebert, B
    Malet, I
    Wirden, M
    Simon, A
    Katlama, C
    Calvez, V
    ANTIVIRAL THERAPY, 2005, 10 : S98 - S98
  • [10] Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in experienced patients
    Marcelin, AG
    Roquebert, B
    Malet, I
    Wirden, M
    Simon, A
    Katlama, C
    Calvez, V
    ANTIVIRAL THERAPY, 2005, 10 (04) : S98 - S98
12345